SCHEMBL7204438

SCHEMBL7204438

CN1CCC(c2c[nH]c3ccc(CC(=O)c4cccc(Cl)c4)cc23)CC1

nearest known ligand 0.53

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HTR1D P28221 13/20 0.53
HTR1B P28222 13/20 0.53
CYP1A2 P05177 1/20 0.53
CYP3A4 P08684 1/20 0.53
CYP2D6 P10635 1/20 0.53
CYP2C9 P11712 1/20 0.53
THPO P40225 1/20 0.53
HTR1A P08908 3/20 0.52
HTR1F P30939 2/20 0.52
MAPT P10636 1/20 0.51
BLM P54132 1/20 0.51
NPSR1 Q6W5P4 1/20 0.51
OPRM1 P35372 1/20 0.50
OPRK1 P41145 1/20 0.50
OPRL1 P41146 1/20 0.50
NOS1 P29475 1/20 0.49
HTR6 P50406 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7203958 0.89 HTR1D (0.55) HTR1DHTR1BCYP1A2CYP3A4CYP2D6
SCHEMBL7208615 0.89 HTR1D (0.53) HTR1DHTR1BCYP1A2CYP3A4CYP2D6
SCHEMBL7205054 0.89 HTR1D (0.53) HTR1DHTR1BCYP1A2CYP3A4CYP2D6
SCHEMBL7202870 0.87 HTR1D (0.52) HTR1DHTR1BCYP1A2CYP3A4CYP2D6
SCHEMBL7202271 0.87 HTR1D (0.56) HTR1DHTR1BCYP1A2CYP3A4CYP2D6
SCHEMBL7201088 0.87 HTR1D (0.52) HTR1DHTR1BCYP1A2CYP3A4CYP2D6
SCHEMBL7202941 0.85 HTR1D (0.54) HTR1DHTR1BCYP1A2CYP3A4CYP2D6
SCHEMBL7205055 0.85 HTR1D (0.56) HTR1DHTR1BCYP1A2CYP3A4CYP2D6
SCHEMBL7205831 0.84 HTR1D (0.53) HTR1DHTR1BCYP1A2CYP3A4CYP2D6
SCHEMBL7204458 0.84 HTR1D (0.52) HTR1DHTR1BCYP1A2CYP3A4CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6608079-B1 Activating serotonin-1F receptors, inhibiting neuronal protein extravasation, treating migraine ELI LILLY AND COMPANY 2003-08-19 US disclosed